Renchi Yang Selected Research

Renchi Yang Research Topics

Disease

74	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 05/2004
25	Hemorrhage 11/2022 - 01/2008
24	Hemophilia A (Haemophilia) 11/2022 - 09/2010
16	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 08/2006
5	Thrombocytopenia (Thrombopenia) 01/2022 - 03/2008
5	Neoplasms (Cancer) 03/2011 - 04/2006
4	Genetic Predisposition to Disease (Genetic Predisposition) 10/2021 - 09/2007
4	Thrombosis (Thrombus) 06/2014 - 12/2008
3	Hemophilia B (Haemophilia B) 07/2022 - 01/2018
3	Respiratory Tract Infections (Respiratory Tract Infection) 02/2022 - 01/2021
3	Essential Thrombocythemia 09/2021 - 10/2004
3	Leukemia 06/2010 - 04/2006
2	Hematologic Diseases (Blood Diseases) 07/2022 - 01/2020
2	Fever (Fevers) 07/2022 - 12/2014
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2021
2	Polycythemia Vera 09/2021 - 10/2004
2	Infections 01/2015 - 01/2006
2	Ecchymosis 09/2014 - 07/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2010 - 02/2008
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2010 - 10/2004
2	Hypoxia (Hypoxemia) 10/2008 - 08/2006
2	Hematologic Neoplasms (Hematological Malignancy) 05/2007 - 04/2002
1	Hematuria 01/2021
1	COVID-19 11/2020
1	Joint Diseases (Joint Disease) 01/2020
1	Hypertriglyceridemia 01/2020
1	Thrombasthenia (Glanzmann Thrombasthenia) 01/2020
1	Hypoprothrombinemias (Prothrombin Deficiency) 02/2016
1	Undifferentiated Connective Tissue Diseases 02/2016
1	Menorrhagia 02/2016
1	Inflammation (Inflammations) 01/2016

Drug/Important Bio-Agent (IBA)

72	Inosine Triphosphate (ITP)IBA 01/2022 - 05/2004
16	Factor VIII (Coagulation Factor VIII)IBA 11/2022 - 09/2010
6	AntibodiesIBA 07/2022 - 07/2005
6	CytokinesIBA 11/2017 - 08/2006
5	Proteins (Proteins, Gene)FDA Link 07/2022 - 04/2002
5	Thrombopoietin (c-mpl Ligand)IBA 01/2017 - 10/2004
5	Messenger RNA (mRNA)IBA 07/2011 - 04/2002
4	GlucocorticoidsIBA 07/2022 - 01/2014
4	Prothrombin (Factor II)IBA 01/2021 - 07/2014
4	AutoantibodiesIBA 12/2019 - 01/2008
3	Heme (Haem)IBA 05/2022 - 05/2019
3	InterferonsIBA 09/2021 - 09/2007
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2021 - 02/2016
3	Rituximab (Mabthera)FDA Link 12/2014 - 01/2008
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 07/2022 - 05/2021
2	eltrombopag FDA Link 01/2022 - 01/2017
2	hetrombopagIBA 01/2022 - 01/2021
2	Thrombopoietin ReceptorsIBA 01/2021 - 01/2017
2	Pharmaceutical PreparationsIBA 07/2020 - 03/2011
2	ChemokinesIBA 07/2017 - 06/2010
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017 - 01/2016
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 02/2016 - 07/2014
2	Therapeutic UsesIBA 04/2015 - 05/2012
2	Interleukin-18 (Interleukin 18)IBA 09/2014 - 08/2014
2	MicroRNAs (MicroRNA)IBA 09/2014 - 06/2010
2	Interleukin-4 (Interleukin 4)IBA 01/2010 - 09/2007
2	LigandsIBA 01/2009 - 04/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2008 - 05/2007
2	AntigensIBA 08/2006 - 07/2005
2	LeptinIBA 08/2006 - 05/2004
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 11/2022
1	Transaminases (Aminotransferases)IBA 07/2022
1	Monoclonal AntibodiesIBA 02/2022
1	emicizumabIBA 02/2022
1	romiplostim FDA Link 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2021
1	Factor VII (Proconvertin)IBA 01/2021
1	IsoantibodiesIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	recombinant factor VIII SQIBA 01/2020
1	recombinant factor VIII N8IBA 01/2020
1	AlbuminsIBA 01/2020
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2020
1	IntegrinsIBA 01/2020
1	EpitopesIBA 12/2019
1	human F8 protein FDA Link 05/2019
1	Complementary DNA (cDNA)IBA 01/2018
1	Chemokine CXCL16IBA 11/2017
1	Interleukin-17 (Interleukin 17)IBA 07/2017
1	sugar formulated recombinant FVIIIIBA 04/2017
1	Sucrose (Saccharose)IBA 04/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	Amino Acids FDA Link 01/2017
1	CD40 Ligand (CD40L)IBA 01/2017
1	Long Noncoding RNAIBA 11/2016
1	Danazol (Azol)FDA LinkGeneric 11/2016
1	Methylprednisolone FDA LinkGeneric 02/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2016
1	EnzymesIBA 01/2016
1	LipidsIBA 01/2016
1	UbiquitinIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016

Therapy/Procedure

19	Therapeutics 07/2022 - 01/2004
4	Splenectomy 03/2017 - 11/2005
2	Injections 11/2022 - 09/2021
2	Aftercare (After-Treatment) 02/2016 - 09/2014
1	Intravenous Infusions 07/2022
1	Drug Tapering 01/2022
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2017